Orbis Allan Gray LtdOrbis Allan Gray Ltd

Institutional investor · Portfolio as of Q2 2020

SEC EDGAR SourceSEC Filings

Top Holdings61 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
NTESNTES
ADR

NETEASE INC-ADR

5.9M$2.5B18.9%$42.10+85.89%
6 qtrssince 2019-Q1
Decreased
0

XPO INC

17.4M$1.3B10.1%$18.59+40.08%
6 qtrssince 2019-Q1
Decreased
0

ABBVIE INC

10.5M$1B7.8%$59.72+28.48%
6 qtrssince 2019-Q1
Decreased
0

ANTHEM INC

3.4M$885.3M6.7%$246.62-2.41%
6 qtrssince 2019-Q1
Increased
67
BTIBTI
ADR

BRITISH AMERICAN TOB-SP ADR

17.3M$672.2M5.1%$23.07+8.83%
6 qtrssince 2019-Q1
Increased
71

COMCAST CORP-CLASS A

16.9M$657.1M4.9%$29.04+6.84%
4 qtrssince 2019-Q3
Increased
78

UNITEDHEALTH GROUP INC

2.2M$654.3M4.9%$214.64+23.48%
6 qtrssince 2019-Q1
Decreased
0

HOWMET AEROSPACE INC

37.2M$589.9M4.4%$13.25+17.81%
2 qtrssince 2020-Q1
Increased
79

META PLATFORMS INC-CLASS A

2.6M$587.2M4.4%$165.53+32.37%
6 qtrssince 2019-Q1
Decreased
0
ATHMATHM
ADR

AUTOHOME INC

7.2M$546.4M4.1%$88.25-25.91%
6 qtrssince 2019-Q1
Decreased
0
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

1.6M$349.1M2.6%$189.92+7.52%
2 qtrssince 2020-Q1
Increased
76
VALEVALE
ADR

VALE SA-SP ADR

31M$320M2.4%$6.82-18.71%
6 qtrssince 2019-Q1
Decreased
0
DAODAO
ADR

YOUDAO INC

8.3M$309.6M2.3%$19.03+94.91%
3 qtrssince 2019-Q4
Increased
55

ALPHABET INC-CL C

188,172$266M2.0%$57.24+20.96%
6 qtrssince 2019-Q1
Decreased
0
FMXFMX
Unit

FOMENTO ECONOMICO MEXICANO SAB /1 ADR REPRS 10 UT CONS 10 SERB &20 SER D-B SHS &20 SER D-L/

3.8M$238M1.8%$67.08-20.21%
6 qtrssince 2019-Q1
Increased
69
ARNCARNCDelisted

ARCONIC CORPORATION

16.6M$230.9M1.7%
1 qtr
New
70

WALT DISNEY CO/THE

2.1M$229M1.7%$100.55+8.35%
6 qtrssince 2019-Q1
Increased
63
GLDGLD
ETF

SPDR GOLD TRUST

1.3M$211.4M1.6%$122.11+36.45%
6 qtrssince 2019-Q1
Decreased
0
stockAPACHE CORPDelisted
15.6M$211M1.6%$27.55-58.22%
6 qtrssince 2019-Q1
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3.7M$209.2M1.6%$35.03+46.65%
6 qtrssince 2019-Q1
Decreased
0
$13.3B
AUM
61
Positions
Q2 2020
Filing
Rating · 2.5
Quarterly Portfolio Change
-6%Q2'19$13.9B-3%Q3'19$13.5B+6%Q4'19$14.3B-27%Q1'20$10.5B+27%Q2'20$13.3B
Activity profile
$ moved · Q2'20
New16%Increased38%Decreased41%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 quarters
<1Q13%1-4Q26%1-2Y59%2Y+2%

Orbis Allan Gray Ltd manages $13.3B across 61 positions as of Q2 2020. Top holdings: NTES (18.9%), XPO (10.1%), ABBV (7.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q2 2020 Summary

Active quarter - 9 new positions, 11 exits, 20 increased. Top move: HWM (INCREASED, conviction 79). Portfolio: $13.3B across 61 positions.

Top holdings by portfolio weight

Total AUM$13B
NTES18.93%
XPO10.09%
ABBV7.79%
ELV6.66%
BTI5.06%
CMCSA4.94%
UNH4.92%
HWM4.44%
META4.42%
ATHM4.11%
Other2.63%

Portfolio allocation by GICS sector

Sectors11
Communication Services36.19%
Healthcare19.41%
Industrials15.23%
Consumer Defensive8.14%
Unknown5.91%
Basic Materials3.70%
Technology3.35%
Energy3.05%
Consumer Cyclical2.97%
Financial Services1.47%
Other0.58%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Communication Services, Healthcare, Industrials
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record64
Conviction48
Concentration60
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
FSVFSVFIRSTSERVICE CORP NEW
Q3 2024 Q2 2026+3.8M shares+$533.5M
8Q
MCSMCSMARCUS CORP DEL
Q3 2024 Q2 2026+1.4M shares+$42.6M
8Q
BURBURBURFORD CAPITAL LIMITED
Q3 2024 Q2 2026+8.4M shares-$21.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used